SCHEDULE 13D/A

ImmunityBio Inc

Common Stock, par value $0.0001 per share · CUSIP: 45256X103

Event date: 2025-11-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Cambridge Equities, LPReported CIK 0001629222

  Shares: 261,705,814 · Class: 26.6%

• MP 13 Ventures, LLCReported CIK 0001629186

  Shares: 261,705,814 · Class: 26.6%

• NantWorks, LLCReported CIK 0001675760

  Shares: 98,535,253 · Class: 10.0%

• NantMobile, LLCReported CIK 0001567221

  Shares: 47,557,934 · Class: 4.8%

• Nant Capital, LLCReported CIK 0001675758

  Shares: 339,464,529 · Class: 31.5%

• California Capital Equity, LLCReported CIK 0001517764

  Shares: 106,511,412 · Class: 10.8%

• Patrick Soon-ShiongReported CIK 0001189020

  Shares: 743,971,200 · Class: 68.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.